ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Align Technology Funds Research Grants to Universities Worldwide for Advancing Orthodontic and Dental Research

$275,000 in Research Grants to be Funded as Part of its Ongoing Annual Research Awards Program

Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the award of eleven research grants to universities under the company’s thirteenth Annual Research Award Program.

“Align is committed to the advancement of the orthodontic and dental fields and we are pleased to support university research around the world, said Dr. Mitra Derakhshan, Align senior vice president, global clinical. “We are excited to see the findings and future clinical insights about Invisalign® clear aligner treatment and its applicability for a broad range of clinical case types for patients of all ages. Continued research around all aspects of clear aligner treatment will increase awareness within the dental community about the efficacy of clear aligner treatment as compared to traditional appliances.”

The Americas research award recipients for 2023 are:

  • University of Washington (Seattle, US) – Primary Investigator, Dr. Greg Huang
  • University of the Pacific (San Francisco, US) – Primary Investigator, Dr. Heeyeon Suh
  • University of Alberta (Edmonton, Alberta, Canada) – Primary Investigator, Dr. Camila Pacheco-Pereira
  • Uniderp (Campo Grande-MS, Brazil) – Primary Investigator, Dr. Paula Vanessa Peron Oltramari

The European research award recipients for 2023 are:

  • UniCamillus, International Medical University (Rome, Italy) – Primary Investigator, Dr. Roberta Lione
  • Mohammed Bin Rashid University (Dubai, United Arab Emirates) – Primary Investigator, Dr. Sabarinath Prasad
  • Johann Wolfgang Goethe University of Frankfurt (Frankfurt, Germany) – Primary Investigator, Dr. Babak Sayahpour
  • University of Milan (Milan, Italy) – Primary Investigator, Dr. Francesca Gaffuri

The Asia Pacific research award recipients for 2023 are:

  • Sichuan University (Chengdu, China) – Primary Investigator, Dr. Hu Long
  • School of Stomatology Wuhan University (Wuhan, China) – Primary Investigator, Dr. Sanjie Yeweng
  • Mahidol University (Bangkok, Thailand) – Primary Investigator, Dr. Narudol Treethanya

“Over the years, it has been rewarding to see the evolution of research projects and the results that have advanced understanding and awareness of the various approaches for the treatment of malocclusion,” said John Morton, Align vice president, technical fellow. “Align is proud to support these research studies that have directly impacted advancements in clear aligner treatment and provided the scientific information that doctors need to interpret the efficacy of Invisalign® clear aligner treatment.”

The 2023 funded research studies will cover a wide range of topics for projects seeking to better understand treatments in orthodontics and dentistry including, but not limited to: ClinCheck® treatment planning software and cone-beam computed tomography (“CBCT”) integration; Curve of Wilson in the lower arch using aligners vs. fixed appliances; comparing the pre-treatment characteristics, demographics, efficiency & effectiveness, prevalence and extent of white-spot-lesions in adolescents treated with aligners vs. fixed appliances in an academic setting; comparing the maxillary and mandibular arch changes with aligners vs. removable palatal expansion and Schwarz appliances; evaluating the treatment outcomes with clear aligner therapy during mixed dentition in transverse and vertical dimensions; comparing the microhardness values of the resin composite attachments using different light curing protocols; three-dimensional characteristics of facial soft tissues with Angle Class II malocclusion; clinical effectiveness of virtual root and bone model system; and, orofacial and smile changes with mandibular advancement, precision bite ramps, and craniofacial changes induced by maxillary expansion.

All award applications received were first reviewed and prioritized in a blind evaluation by an independent academic committee. The final recipients were then determined by Align Technology.

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 243 thousand doctor customers and is key to accessing Align’s 500 million consumer market opportunity worldwide. Over the past 25 years, Align has helped doctors treat over 15.1 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align Digital Platform™, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
-1.43 (-0.67%)
AAPL  252.29
+4.84 (1.96%)
AMD  233.08
-1.48 (-0.63%)
BAC  51.28
+0.84 (1.67%)
GOOG  253.79
+1.91 (0.76%)
META  716.91
+4.84 (0.68%)
MSFT  513.58
+1.97 (0.39%)
NVDA  183.16
+1.35 (0.74%)
ORCL  291.31
-21.69 (-6.93%)
TSLA  439.31
+10.56 (2.46%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.